Atlas Trials

A Safety Study of SGN-CD47M in Patients With Solid Tumors

Clinical trial NCT03957096 · TERMINATED

Trial details

NCT number
NCT03957096
Sponsor
Seagen Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Soft Tissue SarcomaColorectal CancerHead and Neck Squamous Cell CarcinomaNon-small Cell Lung CarcinomaBreast CarcinomaOvarian CarcinomaExocrine Pancreatic CarcinomaGastric CarcinomaMelanoma
Start date
2019-07-17
Primary completion
2020-09-14
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.